Similarly, in a larger CRC cohort that included patients from all stages (GSE39582, n = 511) [26], PDPN expression was again significantly associated with reduced RFS, both in the entire cohort and in stage II patients (Fig 1B and S1A Fig). This evidence concerns the gene PDPN and colorectal carcinoma.